<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Did Gilead&#x27;s (GILD) $32 Billion AI Bet Just Transform Its Innovation and Global Health Narrative? — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Did Gilead&#x27;s (GILD) $32 Billion AI Bet Just Transform Its Innovation and Global Health Narrative?</h2>
    <div class="badge">2025-09-22T10:27:47+00:00</div>
    <ul>
      <li>Uncover how Gilead Sciences&#x27; forecasts yield a $124.91 fair value , a 9% upside to its current price.</li>
<li>This scenario relies on 3.8% annual revenue growth and a $3.7 billion increase in earnings from the current $6.3 billion.</li>
<li>Read the full narrative on Gilead Sciences (it&#x27;s free!) Gilead Sciences&#x27; outlook anticipates $32.3 billion in revenue and $10.0 billion in earnings by 2028.</li>
<li>Explore 9 other fair value estimates on Gilead Sciences - why the stock might be worth 6% less than the current price!</li>
<li>GILD Community Fair Values as at Sep 2025 Some analysts are far more optimistic, recently projecting revenues as high as US$33.9 billion and much higher profit margins over the next few years, reflecting a belief in rapid uptake of new launches.</li>
<li>One key recent announcement is Gilead’s partnership to supply lenacapavir to underserved regions through PEPFAR, aiming to reach up to two million people by the end of 2025.</li>
<li>Gilead Sciences recently broke ground on a 180,000-square-foot AI-enabled Pharmaceutical Development and Manufacturing Technical Development Center at its Foster City campus, part of a US$32 billion investment plan through 2030, and expanded efforts to deliver HIV prevention therapies in partnership with PEPFAR to underserved countries.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Did%20Gilead%27s%20%28GILD%29%20%2432%20Billion%20AI%20Bet%20Just%20Transform%20Its%20Innovation%20and%20Global%20Health%20Narrative%3F%0A%E2%80%A2%20Uncover%20how%20Gilead%20Sciences%27%20forecasts%20yield%20a%20%24124.91%20fair%20value%20%2C%20a%209%25%20upside%20to%20its%20current%20price.%0A%E2%80%A2%20This%20scenario%20relies%20on%203.8%25%20annual%20revenue%20growth%20and%20a%20%243.7%20billion%20increase%20in%20earnings%20from%20the%20current%20%246.3%20billion.%0A%E2%80%A2%20Read%20the%20full%20narrative%20on%20Gilead%20Sciences%20%28it%27s%20free%21%29%20Gilead%20Sciences%27%20outlook%20anticipates%20%2432.3%20billion%20in%20revenue%20and%20%2410.0%20billion%20in%20earnings%20by%202028.%0A%E2%80%A2%20Explore%209%20other%20fair%20value%20estimates%20on%20Gilead%20Sciences%20-%20why%20the%20stock%20might%20be%20worth%206%25%20less%20than%20the%20current%20price%21%0A%E2%80%A2%20GILD%20Community%20Fair%20Values%20as%20at%20Sep%202025%20Some%20analysts%20are%20far%20more%20optimistic%2C%20recently%20projecting%20revenues%20as%20high%20as%20US%2433.9%20billion%20and%20much%20higher%20profit%20margins%20over%20the%20next%20few%20years%2C%20reflecting%20a%20belief%20in%20rapid%20uptake%20of%20new%20launches.%0A%E2%80%A2%20One%20key%20recent%20announcement%20is%20Gilead%E2%80%99s%20partnership%20to%20supply%20lenacapavir%20to%20underserved%20regions%20through%20PEPFAR%2C%20aiming%20to%20reach%20up%20to%20two%20million%20people%20by%20the%20end%20of%202025.%0A%E2%80%A2%20Gilead%20Sciences%20recently%20broke%20ground%20on%20a%20180%2C000-square-foot%20AI-enabled%20Pharmaceutical%20Development%20and%20Manufacturing%20Technical%20Development%20Center%20at%20its%20Foster%20City%20campus%2C%20part%20of%20a%20US%2432%20billion%20investment%20plan%20through%202030%2C%20and%20expanded%20efforts%20to%20deliver%20HIV%20prevention%20therapies%20in%20partnership%20with%20PEPFAR%20to%20underserved%20countries.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fdid-gilead-s-gild-32-billion-ai-bet-just-transform-its-innovation-and-global-hea%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/did-gileads-gild-32-billion-102747481.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>